To include your compound in the COVID-19 Resource Center, submit it here.

FDA issues draft guidance on QIDPs

FDA issued a draft guidance on Qualified Infectious Disease Product (QIDP) designation, clarifying several of its policies and procedures including eligibility criteria and exceptions

Read the full 246 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE